AML with normal cytogenetics accounts for ~50% of all AML, and this subtype of AML is notable for recurrent mutations in several genes: NPM1, CEBPA, TET2, IDH, DNMT3A and FLT3. This evidence concerns the gene NPM1 and acute myeloid leukemia.